When radioactive iodine is dosed more precisely based on thyroid size, it is more likely to permanently destroy the gland and cause lifelong hypothyroidism, regardless of whether the patient had a temporary drop in thyroid function.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review would determine the optimal dose per gram threshold that maximizes permanent hypothyroidism while minimizing treatment failure across diverse populations and measurement methods.
A systematic review and meta-analysis of prospective cohort studies reporting radioactive iodine dosing (mCi/g) and long-term thyroid function outcomes in Graves' disease, including ≥15 studies with standardized thyroid volume measurement (ultrasound), dose calculation methods, and outcome definitions (TSH >10 mIU/L at 12+ months).
An RCT could determine whether a fixed dose per gram (e.g., 180 vs. 120 Gy) causes different rates of permanent hypothyroidism, isolating dosing as the causal variable.
A double-blind, randomized trial of 500 adults with Graves' disease and thyroid volume 30–60 mL, randomized to receive radioactive iodine dosed at 180 Gy vs. 120 Gy per gram of thyroid tissue, with primary outcome: permanent hypothyroidism (TSH >10 mIU/L at 12 months) and secondary outcomes: time to hypothyroidism and recurrence rate.
A prospective cohort study could determine whether dose per gram independently predicts permanent hypothyroidism after adjusting for TRAb, age, and ETH status.
A prospective cohort of 600 adults with Graves' disease, all treated with radioactive iodine dosed by ultrasound-measured thyroid volume, followed for 24 months with monthly thyroid function tests; primary outcome: permanent hypothyroidism (TSH >10 mIU/L on two occasions >3 months apart), adjusted for baseline TRAb, age, and ETH status.
A case-control study could compare the dose per gram received by patients who developed permanent hypothyroidism versus those who remained hyperthyroid or euthyroid.
A case-control study of 200 patients with Graves' disease: 100 cases with permanent hypothyroidism (TSH >10 mIU/L at 24 months) and 100 controls with persistent euthyroidism or hyperthyroidism, matched for age, sex, baseline TRAb, and thyroid volume, with retrospective assessment of calculated radioactive iodine dose per gram.
A cross-sectional study could describe the distribution of dose per gram among patients with established permanent hypothyroidism, but cannot determine whether dosing caused the outcome.
A cross-sectional survey of 300 adults with permanent hypothyroidism (>2 years post-radioactive iodine) for Graves' disease, assessing the calculated radioactive iodine dose per gram of thyroid tissue at time of treatment, using medical records.